The scientific and technological objectives of the proposed project are:

• to quantify features that are visible to the naked eye.
• to quantify features that are not visible to the naked eye.
• to provide a platform that will facilitate the early diagnosis of malignant melanoma.
• to support decision making towards the early diagnosis of malignant melanoma.
• to validate and evaluate the MARK1 project’s results

The MARK1 platform architecture follows a layered approach, which is graphically illustrated in the following figure: